Agmore Breakthrough Corp. is a small biotech company listed on the TSX. To conserve cash, the company frequently settles obligations through the issuance of options. Shares are now trading for $7 per share but have fluctuated between $5 and $21 in the last year. Selected transactions:
a. Issued options to the company lawyer for legal work done to date. These options allow purchase of 80,000 shares at $5 per share at any time over the next three years. The lawyer had billed $261,000, but the company felt it could have negotiated this down slightly—perhaps 15%—for cash payment.
b. Issued options that allow purchase of 300,000 common shares at $7 per share at any time over the next two years. The options were issued for $172,000 cash.
c. Issued options to a customer allowing the customer to receive 50,000 common shares in three years’ time, for no cash cost. The options have been granted based on the long service relationship between the two companies, are fully vested, and are unconditional.
d. Options in (a) and (c) above were exercised when the shares were trading at $13 per share. Options in (b) later expired.

Required:
Provide journal entries to record the transactions listed above. Justify the values used, where possible.